This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
This guide analyzes beta values across leading coins to identify those with the lowest market sensitivity. Explore interpretation and strategy tips.
26,618 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
GE Vernova sparked intraday excitement as investors reacted to new outlooks on its energy portfolio. This piece break...
A sharp move like integer stock down insider signals attention, not alarm. Learn how to read insider trades, separate...
A renowned remote-work strategist warns that the 2026 labor market remains tight and cautious. Workers tied to curren...
Shield AI just unveiled a landmark Series G round worth $1.5 billion, lifting its valuation to $12.7 billion and sett...
A caller facing a $7,000 IRS bill on The Ramsey Show was urged to pay immediately to avoid steep penalties and daily-...
A veteran portfolio manager recounts selling a 19-bagger too early and explains how that misstep reshaped his long-te...
A new class-action settlement over Apple’s advertising claims could put money back in the hands of iPhone buyers. The...
A rapid Trump-backed rally has pushed stocks to fresh highs, yet selective bargains remain. The market shows pockets ...
The jeffrey epstein mystery deepens as a disputed note stirs questions about truth, trust, and how the wealthy plan f...
Santa Clara County filed a landmark lawsuit against Meta, accusing the company of profiting from scam advertisements ...
A sharp one-day drop in ZoomInfo’s shares has investors weighing growth against profitability. This analysis explains...